Sonnet BioTherapeutics (SONN)
(Delayed Data from NSDQ)
$2.65 USD
-0.16 (-5.69%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.71 +0.06 (2.26%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Sonnet BioTherapeutics Holdings, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SONN 2.65 -0.16(-5.69%)
Will SONN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SONN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SONN
Sonnet BioTherapeutics (SONN) Expands Cancer Drug Study
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with ...
Sonnet BioTherapeutics expands clinical evaluation of SON-1010 dose escalation
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session